Key statistics
On Friday, AIM Vaccine Co Ltd (6660:HKG) closed at 8.36, 111.65% above the 52 week low of 3.95 set on Sep 10, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 7.93 |
---|---|
High | 8.42 |
Low | 7.63 |
Bid | 8.35 |
Offer | 8.36 |
Previous close | 7.51 |
Average volume | 13.33m |
---|---|
Shares outstanding | 1.21bn |
Free float | 220.92m |
P/E (TTM) | -- |
Market cap | 9.10bn HKD |
EPS (TTM) | -1.07 HKD |
Data delayed at least 15 minutes, as of Nov 01 2024 08:08 BST.
More ▼
- AIM Vaccine’s 13-valent pneumonia conjugate vaccine obtained Production license
- AIM Vaccine’s heavyweight single-product mRNA RSV Vaccine obtained the clinical trial approval
- Phase III clinical data of AIM Vaccine iterative serum-free rabies vaccine reaches preset goals
- The bull market of innovative drug technology is booming, and the leading stock AIM Vaccine has erupted upward